Jorg Morf

Jorg Morf is a Senior Principal Scientist at Skyhawk Therapeutics, where engagement began in March 2021, after serving as Principal Scientist. Prior experience includes positions as an Associate and Visiting Scientist at the University of Cambridge from July 2018 to March 2021, and as a Scientific Consultant at Scipio Bioscience from January 2018 to June 2020. Jorg Morf's career also features a tenure as a Postdoctoral Research Fellow at The Babraham Institute from November 2012 to July 2018.